share_log

Picton Mahoney Asset Management Acquires New Holdings in Healthcare AI Acquisition Corp. (NASDAQ:HAIAW)

Defense World ·  Aug 29, 2022 06:41

Picton Mahoney Asset Management purchased a new position in shares of Healthcare AI Acquisition Corp. (NASDAQ:HAIAW – Get Rating) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 137,500 shares of the company's stock, valued at approximately $26,000.

Separately, Highbridge Capital Management LLC acquired a new stake in shares of Healthcare AI Acquisition during the 1st quarter worth about $121,000.

Get Healthcare AI Acquisition alerts:

Healthcare AI Acquisition Stock Performance

Healthcare AI Acquisition stock opened at $0.15 on Monday. Healthcare AI Acquisition Corp. has a 12-month low of $0.08 and a 12-month high of $0.41. The business's 50-day moving average price is $0.17.

About Healthcare AI Acquisition

(Get Rating)

Healthcare AI Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It focuses on healthcare and pharmaceutical companies in the e-clinical, healthcare information technology, or outsourced pharmaceutical services industries.

Further Reading

  • Get a free copy of the StockNews.com research report on Healthcare AI Acquisition (HAIAW)
  • Why Trading Volume is Unusually High on These 3 Stocks
  • Can NetApp Resume Its Rally After Strong Earnings Guidance?
  • Three Reasons Why Medtronic Stock can be a Recession Winner
  • Rivian Rising to the Challenge
  • 3 Deflation Enablers Stocks that Can Thrive in a Recession

Receive News & Ratings for Healthcare AI Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare AI Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment